Logo image of CE

CELANESE CORP (CE) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CE - US1508701034 - Common Stock

42.8 USD
-0.09 (-0.21%)
Last: 12/30/2025, 8:04:00 PM
42.8 USD
0 (0%)
After Hours: 12/30/2025, 8:04:00 PM
Fundamental Rating

3

Overall CE gets a fundamental rating of 3 out of 10. We evaluated CE against 83 industry peers in the Chemicals industry. CE may be in some trouble as it scores bad on both profitability and health. CE has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CE was profitable.
In the past year CE had a positive cash flow from operations.
CE had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CE had a positive operating cash flow.
CE Yearly Net Income VS EBIT VS OCF VS FCFCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

CE's Return On Assets of -13.95% is on the low side compared to the rest of the industry. CE is outperformed by 79.52% of its industry peers.
The Return On Equity of CE (-78.22%) is worse than 86.75% of its industry peers.
CE has a Return On Invested Capital of 3.60%. This is comparable to the rest of the industry: CE outperforms 50.60% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CE is in line with the industry average of 6.09%.
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROIC 3.6%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
CE Yearly ROA, ROE, ROICCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

CE has a Operating Margin (8.72%) which is in line with its industry peers.
CE's Operating Margin has declined in the last couple of years.
The Gross Margin of CE (21.33%) is worse than 62.65% of its industry peers.
In the last couple of years the Gross Margin of CE has declined.
Industry RankSector Rank
OM 8.72%
PM (TTM) N/A
GM 21.33%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
CE Yearly Profit, Operating, Gross MarginsCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

CE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CE has been increased compared to 1 year ago.
Compared to 5 years ago, CE has less shares outstanding
CE has a worse debt/assets ratio than last year.
CE Yearly Shares OutstandingCE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
CE Yearly Total Debt VS Total AssetsCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 1.47, we must say that CE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.47, CE is doing worse than 63.86% of the companies in the same industry.
CE has a debt to FCF ratio of 12.55. This is a negative value and a sign of low solvency as CE would need 12.55 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.55, CE is in line with its industry, outperforming 59.04% of the companies in the same industry.
A Debt/Equity ratio of 2.99 is on the high side and indicates that CE has dependencies on debt financing.
With a Debt to Equity ratio value of 2.99, CE is not doing good in the industry: 85.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Altman-Z 1.47
ROIC/WACC0.5
WACC7.24%
CE Yearly LT Debt VS Equity VS FCFCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.63 indicates that CE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.63, CE is doing worse than 62.65% of the companies in the same industry.
CE has a Quick Ratio of 1.04. This is a normal value and indicates that CE is financially healthy and should not expect problems in meeting its short term obligations.
CE has a Quick ratio of 1.04. This is in the lower half of the industry: CE underperforms 62.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.04
CE Yearly Current Assets VS Current LiabilitesCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

The earnings per share for CE have decreased strongly by -47.48% in the last year.
CE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.59% yearly.
CE shows a decrease in Revenue. In the last year, the revenue decreased by -7.34%.
The Revenue has been growing by 10.30% on average over the past years. This is quite good.
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
Revenue 1Y (TTM)-7.34%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%

3.2 Future

Based on estimates for the next years, CE will show a small growth in Earnings Per Share. The EPS will grow by 3.78% on average per year.
The Revenue is expected to decrease by -0.25% on average over the next years.
EPS Next Y-47.33%
EPS Next 2Y-17.48%
EPS Next 3Y-5.35%
EPS Next 5Y3.78%
Revenue Next Year-6.77%
Revenue Next 2Y-3.29%
Revenue Next 3Y-1.25%
Revenue Next 5Y-0.25%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CE Yearly Revenue VS EstimatesCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
CE Yearly EPS VS EstimatesCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

7

4. Valuation

4.1 Price/Earnings Ratio

CE is valuated reasonably with a Price/Earnings ratio of 8.92.
Based on the Price/Earnings ratio, CE is valued cheaper than 90.36% of the companies in the same industry.
CE is valuated cheaply when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 7.53, which indicates a rather cheap valuation of CE.
Based on the Price/Forward Earnings ratio, CE is valued cheaper than 90.36% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.35, CE is valued rather cheaply.
Industry RankSector Rank
PE 8.92
Fwd PE 7.53
CE Price Earnings VS Forward Price EarningsCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

60.24% of the companies in the same industry are more expensive than CE, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CE indicates a rather cheap valuation: CE is cheaper than 95.18% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.58
EV/EBITDA 9.84
CE Per share dataCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

CE's earnings are expected to decrease with -5.35% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.48%
EPS Next 3Y-5.35%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.28%, CE is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.48, CE is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.00, CE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.28%

5.2 History

The dividend of CE has a limited annual growth rate of 3.06%.
CE has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of CE decreased recently.
Dividend Growth(5Y)3.06%
Div Incr Years0
Div Non Decr Years1
CE Yearly Dividends per shareCE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

The earnings of CE are negative and hence is the payout ratio. CE will probably not be able to sustain this dividend level.
CE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-2.78%
EPS Next 2Y-17.48%
EPS Next 3Y-5.35%
CE Yearly Income VS Free CF VS DividendCE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

CELANESE CORP

NYSE:CE (12/30/2025, 8:04:00 PM)

After market: 42.8 0 (0%)

42.8

-0.09 (-0.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-16 2026-02-16/amc
Inst Owners103.6%
Inst Owner Change-3.27%
Ins Owners0.28%
Ins Owner Change1.4%
Market Cap4.69B
Revenue(TTM)9.71B
Net Income(TTM)-3.09B
Analysts73.6
Price Target53.83 (25.77%)
Short Float %7.46%
Short Ratio3.77
Dividend
Industry RankSector Rank
Dividend Yield 0.28%
Yearly Dividend2.81
Dividend Growth(5Y)3.06%
DP-2.78%
Div Incr Years0
Div Non Decr Years1
Ex-Date10-28 2025-10-28 (0.03)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.25%
Min EPS beat(2)-0.14%
Max EPS beat(2)6.64%
EPS beat(4)3
Avg EPS beat(4)17.03%
Min EPS beat(4)-0.14%
Max EPS beat(4)44.41%
EPS beat(8)4
Avg EPS beat(8)4.55%
EPS beat(12)6
Avg EPS beat(12)2.25%
EPS beat(16)8
Avg EPS beat(16)2.68%
Revenue beat(2)0
Avg Revenue beat(2)-3.84%
Min Revenue beat(2)-6.31%
Max Revenue beat(2)-1.36%
Revenue beat(4)1
Avg Revenue beat(4)-1.91%
Min Revenue beat(4)-6.31%
Max Revenue beat(4)2.89%
Revenue beat(8)1
Avg Revenue beat(8)-3.49%
Revenue beat(12)1
Avg Revenue beat(12)-4.02%
Revenue beat(16)3
Avg Revenue beat(16)-2.63%
PT rev (1m)-3.65%
PT rev (3m)-3.28%
EPS NQ rev (1m)-3.52%
EPS NQ rev (3m)-15.61%
EPS NY rev (1m)0.22%
EPS NY rev (3m)-2.08%
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)-4.61%
Revenue NY rev (1m)-1.48%
Revenue NY rev (3m)-1.66%
Valuation
Industry RankSector Rank
PE 8.92
Fwd PE 7.53
P/S 0.48
P/FCF 4.58
P/OCF 3.38
P/B 1.19
P/tB N/A
EV/EBITDA 9.84
EPS(TTM)4.8
EY11.21%
EPS(NY)5.69
Fwd EY13.29%
FCF(TTM)9.35
FCFY21.85%
OCF(TTM)12.68
OCFY29.62%
SpS88.68
BVpS36.11
TBVpS-31.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number62.45
Profitability
Industry RankSector Rank
ROA -13.95%
ROE -78.22%
ROCE 4.59%
ROIC 3.6%
ROICexc 3.9%
ROICexgc 6.84%
OM 8.72%
PM (TTM) N/A
GM 21.33%
FCFM 10.55%
ROA(3y)2.64%
ROA(5y)8.38%
ROE(3y)10.61%
ROE(5y)26.65%
ROIC(3y)4.41%
ROIC(5y)7.05%
ROICexc(3y)4.72%
ROICexc(5y)7.67%
ROICexgc(3y)9.71%
ROICexgc(5y)12.05%
ROCE(3y)5.7%
ROCE(5y)9.11%
ROICexgc growth 3Y-25.53%
ROICexgc growth 5Y-7.04%
ROICexc growth 3Y-35.3%
ROICexc growth 5Y-15.71%
OM growth 3Y-23.69%
OM growth 5Y-9.25%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.98%
GM growth 5Y-2.12%
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF 12.55
Debt/EBITDA 7.29
Cap/Depr 47.03%
Cap/Sales 3.75%
Interest Coverage 250
Cash Conversion 85.63%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.04
Altman-Z 1.47
F-Score4
WACC7.24%
ROIC/WACC0.5
Cap/Depr(3y)81.1%
Cap/Depr(5y)93.82%
Cap/Sales(3y)5.01%
Cap/Sales(5y)5.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.48%
EPS 3Y-22.89%
EPS 5Y-2.59%
EPS Q2Q%-45.08%
EPS Next Y-47.33%
EPS Next 2Y-17.48%
EPS Next 3Y-5.35%
EPS Next 5Y3.78%
Revenue 1Y (TTM)-7.34%
Revenue growth 3Y6.39%
Revenue growth 5Y10.3%
Sales Q2Q%-8.65%
Revenue Next Year-6.77%
Revenue Next 2Y-3.29%
Revenue Next 3Y-1.25%
Revenue Next 5Y-0.25%
EBIT growth 1Y-23%
EBIT growth 3Y-18.82%
EBIT growth 5Y0.1%
EBIT Next Year22.66%
EBIT Next 3Y11.82%
EBIT Next 5Y9.04%
FCF growth 1Y-0.29%
FCF growth 3Y-25.61%
FCF growth 5Y-13.3%
OCF growth 1Y-13.79%
OCF growth 3Y-18.08%
OCF growth 5Y-7.85%

CELANESE CORP / CE FAQ

What is the ChartMill fundamental rating of CELANESE CORP (CE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CE.


What is the valuation status for CE stock?

ChartMill assigns a valuation rating of 7 / 10 to CELANESE CORP (CE). This can be considered as Undervalued.


What is the profitability of CE stock?

CELANESE CORP (CE) has a profitability rating of 3 / 10.


Can you provide the financial health for CE stock?

The financial health rating of CELANESE CORP (CE) is 2 / 10.


What is the expected EPS growth for CELANESE CORP (CE) stock?

The Earnings per Share (EPS) of CELANESE CORP (CE) is expected to decline by -47.33% in the next year.